期刊文献+

低剂量HCG诱发排卵后血清HCG水平对IVF卵巢过度刺激综合征高危人群临床结局的影响 被引量:1

下载PDF
导出
摘要 目的在IVF卵巢过度刺激综合征高危人群中使用低剂量HCG诱发排卵,分析注射HCG后次日不同水平HCG的临床结局,及补打HCG的临床效果。方法IVF-ET长方案超促排卵方案中,具有OHSS高危因素的患者HCG日使用HCG 2 000 U诱发排卵,根据次日血中HCG的水平分为HCG≤45 U/L(A组,29人)、45 U/L<HCG<50 U/L(B组,6人)、HCG≥50 U/L(C组,23人)3组,从HCG≤45U/L(29人)中选择20人进行补打HCG 2 000U(D组),同时选择具有OHSS高危因素的患者HCG日使用HCG 6 000U诱发排卵作为参照组(E组,98人)。比较5组的年龄、获卵率、可用胚胎率、临床妊娠率、OHSS发生率等。结果A、B、C、D、E 5组获卵率分别是58.8%、72.1%、76.6%、67.5%、75.2%,与A组相比,B、C、D、E 4组的获卵率均显著增高(P<0.05),B、C、D、E 4组组间比较无显著性差异(P>0.05)。A、B、C、D、E 5组可用胚胎率分别是53.8%、67.9%、64.3%、66.9%、64.5%,B、C、D、E 4组与A组相比均显著增高(P<0.05),B、C、D、E 4组组间比较无显著性差异(P>0.05)。A、B、C、D 4组临床妊娠率和流产率、OHSS率差异无统计意义(P>0.05)。结论次日血中HCG的水平≤45 U/L,显著影响获卵率和可用胚胎率,若次日补打HCG可获得良好临床结局。
出处 《生殖医学杂志》 CAS 2016年第11期1021-1024,共4页 Journal of Reproductive Medicine
  • 相关文献

参考文献8

二级参考文献79

  • 1朱依敏,高惠娟,何荣环,黄荷凤.限制性促排卵方案预防卵巢过度刺激综合征的探索性研究[J].中华妇产科杂志,2006,41(11):740-744. 被引量:10
  • 2葛红山,赵军招,林金菊,张巍,周玮,黄学锋.体外加入hCG不能改善人卵子体外成熟及发育潜能[J].生殖与避孕,2007,27(6):404-409. 被引量:5
  • 3Humaidan P, Quartarolo J, Papanikolaou EG. Preventing ovarian hyperstimulation syndrome: guidance for the clinician. Fertil Steril, 2010, 94(2):389-400.
  • 4Kashyap S, Parker K, Cedars MI, et al. Ovarian hyperstimu- lation syndrome prevention strategies: reducing the human chorionic gonadotropin trigger dose. Sem in Reprod Med, 2010, 28(6):475-85.
  • 5Nargund G. Low-dose hCG is useful in preventing OHSS in high-risk women without adversely affecting the outcome of IVF cycles. Reprod Biomed Online, 2007, 14(6):682-5.
  • 6Schmidt DW, Maler DB, Nulsen JC, et al. Reducing the dose of human chorionic gonadotropin in high responders does not affect the outcomes of in vitro fertilization. Fertil Steril, 2004, 82(4):841-6.
  • 7Aboulghar M. Prediction of ovarian hyperstimulation syn- drome (OHSS). Estradiol level has an important role in the prediction of OHSS. Hum Reprod, 2003, 18(6):1140-1.
  • 8Cummins JM, Breen TM, Harrison KL, et al. Aformula for scoring human embryo growth rates in in vitro fertilization: its value in predicting pregnancy and in comparison with visual estimates of embryo quality. J in Vitro Fertil Embryo Transfer, 1986, 3(5):284-95.
  • 9Gomez R, Soares SR, Busso C, et al. Physiology and pathology of ovarian hyperstimulation syndrome. Sem Reprod Med, 2010, 28(6):448-57.
  • 10The European Recombinant LH Study Group. Recombinant human luteinizing hormone is as effective as, but safer than, urinary human chorionic gonadotropin in inducing final folli- cular maturation and ovulation in in vitro fertilization procedures: results of a multicenter double-blind study. J Clin Endocrinol Metab, 2001, 86(6):2607-18.

共引文献56

同被引文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部